Rutgers Health Rwj Scleroderma Program

Rutgers Health RWJ Scleroderma Program

Template:Medical program navigation This medical program related article is a stub.

```

This template is designed for creating infoboxes for medical programs. It includes fields for the program's name, image, motto, formation date, type, status, purpose, headquarters, location, region served, membership, language, leader title and name, parent organization, affiliations, number of staff and volunteers, budget, website, remarks, and any former names. It also includes a navigation template for medical programs and a stub notice encouraging users to expand the article.

The Rutgers Health RWJ Scleroderma Program is a specialized medical program located in New Brunswick, New Jersey, United States. It is dedicated to the diagnosis, treatment, and research of scleroderma, a chronic autoimmune disease that affects the connective tissues of the body.

Overview

The program is affiliated with the prestigious Robert Wood Johnson University Hospital, which provides state-of-the-art facilities and resources for patient care and research. The Rutgers Health RWJ Scleroderma Program is known for its multidisciplinary approach, bringing together a team of experts from various medical specialties to provide comprehensive care for patients with scleroderma.

Services

The program offers a wide range of services to meet the unique needs of scleroderma patients. These services include:

Diagnosis and Evaluation

The program provides advanced diagnostic techniques to accurately identify and evaluate scleroderma. This includes a thorough medical history review, physical examination, laboratory tests, and imaging studies such as X-rays and MRI scans.

Treatment

The Rutgers Health RWJ Scleroderma Program offers personalized treatment plans tailored to each patient's specific needs. Treatment options may include medication management, physical therapy, occupational therapy, and surgical interventions when necessary. The program also provides access to cutting-edge therapies and clinical trials.

Support and Education

The program recognizes the importance of support and education for patients and their families. It offers support groups, educational resources, and counseling services to help patients cope with the challenges of living with scleroderma.

Research

The Rutgers Health RWJ Scleroderma Program is actively involved in research to advance the understanding and treatment of scleroderma. Its team of researchers collaborates with other institutions and participates in clinical trials to explore new therapies and interventions. The program also conducts studies to identify the underlying causes of scleroderma and develop more effective diagnostic tools.

Notable Achievements

The program has achieved several notable milestones in the field of scleroderma research and patient care. Some of its achievements include:

• Development of innovative treatment approaches that have improved outcomes for scleroderma patients.
• Publication of groundbreaking research papers in reputable medical journals.
• Recognition as a leading center for scleroderma care and research.

External links

• Rutgers Health RWJ Scleroderma Program - Official website